OAK RIDGE, Tenn.--(BUSINESS WIRE)--Standard Nuclear, Inc., a reactor-agnostic producer of TRISO nuclear fuel, announced today that it has executed an Other Transaction Agreement (OTA) with the U.S.

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA ® (zanidatamab), a ...

The tension between the rights of individuals to a private life and increasing demands from states to gain access to people’s private data increased in 2025. During the year, Computer Weekly was the ...

The RansomHouse ransomware-as-a-service (RaaS) has recently upgraded its encryptor, switching from a relatively simple single-phase linear technique to a more complex, multi-layered method. In ...

AIR plans to deliver 19 aircraft to customers in 2026. Credit: AIR Israeli eVTOL developer AIR has delivered its first production-standard aircraft, marking a transition from prototype development and ...

Microsoft is killing off an obsolete and vulnerable encryption cipher that Windows has supported by default for 26 years following more than a decade of devastating hacks that exploited it and ...

Cryptocurrency exchange Coinbase (COIN) and crypto-friendly bank Standard Chartered (STAN) said they expanded a partnership on digital assets to explore the development of trading, prime services, ...

Pret Advanced Materials, LLC, a supplier of thermoplastic resins, has announced an expansion of its operations in Florence County, SC. The $18.5M investment will enhance the company's capabilities and ...

Standard Nuclear, Inc., a reactor-agnostic producer of TRISO nuclear fuel, announced today that it has executed an Other Transaction Agreement (OTA) with the U.S. Department of Energy (DOE), marking a ...

DUBAI, 25th November, 2025 (WAM) -- Standard Chartered announced today the findings of its latest ‘Future of Trade: Digitisation’ report, which identifies the UAE as the most advanced market globally ...

This discussion provides an in-depth overview of the current standard of care for advanced esophageal squamous cell carcinoma (ESCC), with brief parallels to biomarker-driven gastric cancer management ...